Your session is about to expire
← Back to Search
Allograft Implantation
Robot Assisted Radical Prostatectomy with MLG-COMPLETE Allograft for Prostate Cancer
N/A
Waitlist Available
Led By Ashok K Hemal, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights
Summary
This trial aims to see if using an allograft helps improve recovery for prostatectomy patients, improving erectile & bladder function.
Eligible Conditions
- Prostate Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Average Time for Participants to Return to Potency - Sexual Health Inventory for Men (SHIM) Questionnaire
Average Time to Return to Bladder Control/Urinary Continence - ICIQ-UI Short Form
Number of Adverse Events Using the Clavien-Dindo Classification System
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Robot Assisted Radical Prostatectomy with MLG-COMPLETE AllograftExperimental Treatment2 Interventions
Implantation of the MLG-COMPLETE allograft during your robot-assisted radical prostatectomy surgery.
Find a Location
Who is running the clinical trial?
Samaritan BiologicsIndustry Sponsor
1 Previous Clinical Trials
180 Total Patients Enrolled
Wake Forest University Health SciencesLead Sponsor
1,266 Previous Clinical Trials
1,013,707 Total Patients Enrolled
20 Trials studying Prostate Cancer
1,769 Patients Enrolled for Prostate Cancer
Ashok K Hemal, MDPrincipal InvestigatorWake Forest Baptist Comprehensive Cancer Center
1 Previous Clinical Trials
Share this study with friends
Copy Link
Messenger